102 Alliance UniChem Plc Notes to the financial statements for the year ended 31 December 2005 42 ACQUISITIONS Purchase of businesses The Group has continued its development during the year through a number of business acquisitions that have been accounted for by the purchase method of acquisition accounting and are summarised for wholesale and retail acquisitions.
The unaudited pro forma consolidated results of operations acquired during the year, presented as if the acquisitions had been made at the beginning of the financial year, would be as follows: 2005 million Revenue 409.8 Profit attributable to equity shareholders 6.0 The excess of the fair value of the purchase price over the fair value of net assets of businesses acquired in the year, is recognised as goodwill, as follows: Wholesale Book and provisional fair value at acquisition Assets acquired at book and provisional fair value million Intangible assets software 1.0 Property, plant and equipment 25.3 Investments in associates 5.2 Available-for-sale investments 1.0 Deferred tax assets 2.6 Inventories 16.7 Trade and other receivables 66.7 Cash and cash equivalents 5.1 Borrowings bank overdrafts 17.6 bank loans 35.8 finance leases 0.5 Trade and other payables 60.7 Current corporate tax liabilities 0.8 Minority interest 0.4 Net assets acquired 7.8 Consideration paid million Cash 19.4 Deferred consideration 16.3 Non-cash consideration 11.4 47.1 Purchased goodwill 39.3 The non-cash consideration relates to the Groups restructuring of its relationship with Galenica A. G. in which it holds a 25.5% interest in the ordinary share capital.
Under the terms of the restructuring, the Group increased its direct ownership in Alloga S. A. from 20% to 100%, with the exception of the Swiss part of the business, which was fully acquired by Galenica A. G..
In addition, the Group sold its 50% direct interest in the ordinary share capital of GaleniCare S. A. to Galenica A. G..
The consideration for these transactions was settled on a net basis.
Of the purchased goodwill of 39.3 million, 11.4 million relates to the purchase of associates within the Alloga Group.
